Prelude Therapeutics Incorporated Profile Avatar - Palmy Investing

Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select sol…

Biotechnology
US, Wilmington [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Prelude Therapeutics Incorporated has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Prelude Therapeutics Incorporated can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Prelude Therapeutics Incorporated.

End of PRLD's Analysis
CIK: 1678660 CUSIP: 74065P101 ISIN: US74065P1012 LEI: - UEI: -
Secondary Listings
PRLD has no secondary listings inside our databases.